# FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation

> **NCT06260670** · NA · COMPLETED · sponsor: **Ablacon, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Persistent Atrial Fibrillation
- Longstanding Persistent Atrial Fibrillation
- Atrial Fibrillation, Persistent
- Arrhythmias, Cardiac

## Interventions

- **DEVICE:** Electrographic Flow™ Mapping using Ablamap® Software and FIRMap™ Catheter

## Key facts

- **NCT ID:** NCT06260670
- **Lead sponsor:** Ablacon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-10-28
- **Final completion:** 2022-10-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06260670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06260670, "FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06260670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*